Reply to: Is subcutaneous implantable cardioverter-defibrillator testing effective and safe for patients with hypertrophic cardiomyopathy?

Int J Cardiol. 2017 Nov 1:246:55. doi: 10.1016/j.ijcard.2017.03.107.

Authors

Niccolò Maurizi¹, Iacopo Olivotto², Franco Cecchi³

Affiliations

¹ Department of Clinical and Experimental Medicine, University of Florence, Italy; Cardiomyopathy Unit, University Hospital of Careggi, Florence, Italy. Electronic address: niccolo.maurizi@gmail.com.
² Cardiomyopathy Unit, University Hospital of Careggi, Florence, Italy.
³ Arcard Foundation, Florence, Italy.

PMID: 28867016
DOI: 10.1016/j.ijcard.2017.03.107

No abstract available

Publication types

Letter
Comment

MeSH terms

Cardiomyopathy, Hypertrophic*
Death, Sudden, Cardiac
Defibrillators, Implantable*
Humans
Subcutaneous Tissue